Up­dat­ed: Roche pulls PD-L1 block­buster's ac­cel­er­at­ed ap­proval in blad­der can­cer

The FDA’s cleanup on aisle ac­cel­er­at­ed ap­proval con­tin­ued this morn­ing as Roche an­nounced it would vol­un­tar­i­ly pull from the mar­ket an in­di­ca­tion for its block­buster …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER